|
Recent Newsletters
Big news for new-look diabetes drug tirzepatide | Cardiologist makes history | AMI outcomes during the pandemic |
The most common reasons for hospitalization in the US | HCM & AFib |
Economics & Policy: The physician shortage is coming | ‘A victory for people with serious illnesses’ | Beverage taxes work |
Week in Review: High-risk HF patients | AFIb & alcohol | A historic FDA approval | Insulin syringes recalled |
Low heart rate reported in elderly COVID-19 patient | The latest on vaccine-related heart damage | Statin therapy & cancer |
Heart Failure: Disease progression in asymptomatic patients | Vaccine-related heart damage resolves in days |
FDA approves first oral blood thinner for pediatric patients | New metric IDs high-risk HF patients | Think before you eat |